Biondi, Andrea <br/><br/>
Long-term follow up of pediatric Philadelphia positive acute lymphoblastic leukemia treated with the EsPhALL2004 study: high white blood cell count at diagnosis is the strongest prognostic factor.  [electronic resource] 

 -  Haematologica  01 2019 
 - e13-e16 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Letter; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1592-8721 
<br/><br/><label>Standard No.: </label>10.3324/haematol.2018.199422  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Child<br/>Child, Preschool<br/>Disease-Free Survival<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Imatinib Mesylate--administration & dosage<br/>Infant<br/>Leukocyte Count<br/>Male<br/>Philadelphia Chromosome<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--diagnosis<br/>Survival Rate